Abstract
Nanoparticles (NPs) are currently widely used for different applications like cosmetics, personal care products and drug delivery agents. The enormous use and production of NPs resulted in release of NPs into the environment. These NPs find their way into aquatic, terrestrial and atmospheric environments. These NPs interact with their immediate environments and cause adverse affects on them. The rapidly growing field of nanotechnology will result in new routes of exposure through inhalation, ingestion, and injection. They can have damaging effects on cellular organells like mitochondria and macromoleculs like DNA. In view of this, there is a need to better understand the interactions between the NPs, environment and the organisms. In this article, we have reviewed the well known cytotoxicity assays and toxicity associated with therapeutic NPs.
Keywords: Cytotoxicity, NPs, Reactive oxygen species, Oxidative stress, Nanotechnology, Nanotoxicity, Metal NPs, Metal Oxide NPs, Quantum Dots, Silica Nanomaterials
Current Nanoscience
Title: Therapeutic Nanoparticles and Associated Toxicity
Volume: 7 Issue: 3
Author(s): Avnesh Kumari, Vineet Kumar and Sudesh Kumar Yadav
Affiliation:
Keywords: Cytotoxicity, NPs, Reactive oxygen species, Oxidative stress, Nanotechnology, Nanotoxicity, Metal NPs, Metal Oxide NPs, Quantum Dots, Silica Nanomaterials
Abstract: Nanoparticles (NPs) are currently widely used for different applications like cosmetics, personal care products and drug delivery agents. The enormous use and production of NPs resulted in release of NPs into the environment. These NPs find their way into aquatic, terrestrial and atmospheric environments. These NPs interact with their immediate environments and cause adverse affects on them. The rapidly growing field of nanotechnology will result in new routes of exposure through inhalation, ingestion, and injection. They can have damaging effects on cellular organells like mitochondria and macromoleculs like DNA. In view of this, there is a need to better understand the interactions between the NPs, environment and the organisms. In this article, we have reviewed the well known cytotoxicity assays and toxicity associated with therapeutic NPs.
Export Options
About this article
Cite this article as:
Kumari Avnesh, Kumar Vineet and Kumar Yadav Sudesh, Therapeutic Nanoparticles and Associated Toxicity, Current Nanoscience 2011; 7 (3) . https://dx.doi.org/10.2174/157341311795542381
DOI https://dx.doi.org/10.2174/157341311795542381 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Current Pharmaceutical Biotechnology NMN/NaMN Adenylyltransferase (NMNAT) and NAD Kinase (NADK) Inhibitors: Chemistry and Potential Therapeutic Applications
Current Medicinal Chemistry Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy
Current Cancer Drug Targets The Enzymology of Cytosolic Pyrimidine 5’-Nucleotidases: Functional Analysis and Physiopathological Implications.
Current Medicinal Chemistry Target Identification of Grape Seed Extract in Colorectal Cancer Using Drug Affinity Responsive Target Stability (DARTS) Technique: Role of Endoplasmic Reticulum Stress Response Proteins
Current Cancer Drug Targets Targeting the Multidrug ABCG2 Transporter with Flavonoidic Inhibitors: In Vitro Optimization and In Vivo Validation
Current Medicinal Chemistry Fetal Mesenchymal Stem Cells in Cancer Therapy
Current Stem Cell Research & Therapy Cytotoxic Properties of Clofibrate and other Peroxisome Proliferators: Relevance to Cancer Progression
Current Medicinal Chemistry MMPs in Ovarian Cancer as Therapeutic Targets
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Silencing Human Cancer: Identification and Uses of MicroRNAs
Recent Patents on Anti-Cancer Drug Discovery Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry - Central Nervous System Agents Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
Current Pharmaceutical Design Role of Generation, Architecture, pH and Ionic Strength on Successful siRNA Delivery and Transfection by Hybrid PPV-PAMAM Dendrimers
Current Medicinal Chemistry Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry Patents and the Development on Polymer based Nanomaterial (PAMAM Dendrimer) for Biomedical Applications
Recent Patents on Biomedical Engineering (Discontinued) Morin Inhibits Ovarian Cancer Growth through the Inhibition of NF-κB Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry Terpenoids form the Sea: Chemical Diversity and Bioactivity
Current Organic Chemistry Synthesis, Biological Evaluation and Docking Studies of 1,3,4-Oxadiazole Fused Benzothiazole Derivatives for Anticancer Drugs
Letters in Drug Design & Discovery